Research to Prevent Blindness

Prevent Blindness Recognized as a Healthy People 2030 Champion for Supporting the Initiative's Vision

Retrieved on: 
星期四, 八月 4, 2022
People, Office of the Assistant Secretary for Preparedness and Response, Physical Activity Guidelines for Americans, Fitness, Visual impairment, CEO, Office of Inspector General, U.S. Department of Health and Human Services, Assistant, YouTube, Health Promotion International, Research to Prevent Blindness, Health, Research, Human services, Instagram, Twitter, Education, Severe cognitive impairment, Awareness, Diabetes, Goal, Dietary Guidelines for Americans, HHS, MD, LinkedIn, Fortis Healthcare, President's Emergency Plan for AIDS Relief, Healthy People program, Organization, Dietary supplement, Pharmaceutical industry, Sport, Facebook

CHICAGO, Aug. 4, 2022 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading voluntary eye health and safety nonprofit organization, is pleased to be recognized by the Office of Disease Prevention and Health Promotion (ODPHP) within the U.S. Department of Health and Human Services (HHS) as a Healthy People 2030 Champion.

Key Points: 
  • As a Healthy People 2030 Champion, Prevent Blindness has demonstrated a commitment to helping achieve the Healthy People 2030 vision of a society in which all people can achieve their full potential for health and well-being across the lifespan.
  • Prevent Blindness has been a collaborator with the Healthy People Initiative for several decades.
  • "At Prevent Blindness, we are excited that vision and eye health are included as key components in the overall objectives for Healthy People 2030," said Jeff Todd, president and CEO of Prevent Blindness.
  • "ODPHP is thrilled to recognize Prevent Blindness for its work to support the Healthy People 2030 vision," says RADM Paul Reed, MD, ODPHP Director.

Prevent Blindness Offers Webinars, Services and Free Resources for August's Children's Eye Health and Safety Month During the "Year of Children's Vision"

Retrieved on: 
星期三, 七月 27, 2022
Steps, Education, New England College of Optometry, Twitter, Instagram, Student, Visual impairment, List of Facebook features, Social media, CEO, Glasses, Curriculum, Research, Vision, Eye Health UK, Partnership, Parent, National Association, Vision Forum, RN, Severe cognitive impairment, National Center for Children in Poverty, Distressed Children & Infants International, Safety, Optometry, CAE, Research to Prevent Blindness, MS, Caregiver, Patient, LinkedIn, National Association of School Nurses, Doctor of Education, OD, National Center for Healthy Housing, Nursing, Pharmaceutical industry, Birth control, Telescopic sight, Health insurance, Facebook, Hope

CHICAGO, July 27, 2022 /PRNewswire-PRWeb/ -- August is Children's Eye Health and Safety Month, and 2022 is the "Year of Children's Vision" at national non-profit, Prevent Blindness. The nation's leading volunteer eye health and safety organization is offering a wide variety of free resources, including educational tool kits, fact sheets, webinars, and more, to provide parents, caregivers, teachers, school nurses and public health professionals the information they need to help keep children's eyes healthy and ensure that children are ready to learn and succeed in school, activities and development.

Key Points: 
  • CHICAGO, July 27, 2022 /PRNewswire-PRWeb/ --August is Children's Eye Health and Safety Month, and 2022 is the "Year of Children's Vision" at national non-profit, Prevent Blindness .
  • The National Center for Children's Vision and Eye Health at Prevent Blindness (NCCVEH) has an extensive library of free informational resources about vision health for children from infants to teens.
  • Available in August, Prevent Blindness and the NCCVEH will offer:
    a new episode in the online Focus on Eye Health Expert Series, "Partnering with School Nurses for Children's Vision and Eye Health."
  • Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight.

Ocular Therapeutix™ Announces Organizational Changes to Support Development for Retinal Diseases

Retrieved on: 
星期三, 六月 8, 2022
Research, Surgery, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, Optical, Science, Harvard College, Lew, Company, Rest, Allergic conjunctivitis, Harvard Medical School, Macula of retina, Inflammation, Pain, Private Securities Litigation Reform Act, Massachusetts General Hospital, COVID-19, Research, Biogen, The Highest Honor, U.S. Securities and Exchange Commission, Research to Prevent Blindness, Ocular hypertension, Knowledge, Nightstar, News, Axitinib, Visual impairment, AMD, Duane syndrome, List of lifetime achievement awards, Akouo, CFDA, Pharmacovigilance, American Journal of Ophthalmology, EMA, American Academy, Standard of care, Security (finance), Cleveland, Patient, Rabia, Internal medicine, Cleveland Clinic, Society, Editing, Bascom Palmer Eye Institute, Massachusetts Eye and Ear, Drug, FDA, NASDAQ, Clinical trial, PMDA, Hospital, Pharmaceutical industry, Management, Retina, Ophthalmology, Eye

In this role, Dr. Kaiser will advise on clinical development strategies for Ocular Therapeutixs retina programs including OTX-TKI, currently in Phase 1 development in the United States and Australia for the treatment of wet age-related macular degeneration (wet AMD) and other retinal diseases.

Key Points: 
  • In this role, Dr. Kaiser will advise on clinical development strategies for Ocular Therapeutixs retina programs including OTX-TKI, currently in Phase 1 development in the United States and Australia for the treatment of wet age-related macular degeneration (wet AMD) and other retinal diseases.
  • Dr. Kaiser is also expected to advise on pre-clinical development work for Oculars gene therapy delivery and complement inhibition development programs.
  • Prior to joining Ocular in 2021, Dr. Gurses Ozden served as the Chief Development Officer at Akouos, Inc.
  • Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology.

Call for Nominations Issued for the 2022 Bonnie Strickland Champion for Children's Vision Award from the NCCVEH at Prevent Blindness

Retrieved on: 
星期三, 六月 1, 2022
National Center for Immunization and Respiratory Diseases, NUALS Arts and Literary Annual Meet, Severe cognitive impairment, NBCT, IEI, Leadership, Ohio Department of Health, Research to Prevent Blindness, Research, Doctor of Philosophy, NYS, CEO, National Center for Children in Poverty, Health Resources and Services Administration, Anita Borg Institute Women of Vision Awards, Retirement, Annual general meeting, Utah Division of Services for People with Disabilities, VIP, Nursing, Vision, Mother, Maternal and Child Health Bureau, Optometry, Vanderbilt University, Pediatrics, Public health, ABO, MPH, Health insurance, Weapon, Medicine, Toy, Child, Ophthalmology, Ophthalmology, MD

CHICAGO, June 1, 2022 /PRNewswire-PRWeb/ -- The National Center for Children's Vision and Eye Health at Prevent Blindness (NCCVEH) has issued a call for nominations for the eighth annual "Bonnie Strickland Champion for Children's Vision Award." The highest honor that the NCCVEH bestows, the award recognizes significant efforts by an individual or group of individuals to improve public health approaches for children's vision and eye health at the state or national level. The deadline for submission is August 1, 2022.

Key Points: 
  • CHICAGO, June 1, 2022 /PRNewswire-PRWeb/ -- The National Center for Children's Vision and Eye Health at Prevent Blindness (NCCVEH) has issued a call for nominations for the eighth annual " Bonnie Strickland Champion for Children's Vision Award ."
  • The award will be presented at the Annual Meeting of the NCCVEH, to be held virtually on Friday, Oct. 14, 2022.
  • Nominations for the 2022 Bonnie Strickland Champion for Children's Vision Award may include an individual person or group who is implementing change to improve children's vision health in the United States.
  • The all-volunteer Bonnie Strickland Champion for Children's Vision Award Committee will review all nominations and select the award recipient or recipients.

 Grant From Research to Prevent Blindness and Castle Biosciences Supports Medical Student Research in Ocular Cancer

Retrieved on: 
星期五, 五月 20, 2022
Research, Continuing, Health, University, General Health, Optical, Science, Education, Oncology, Cancer, Knowledge, Investor, Uveal melanoma, David Geffen School of Medicine at UCLA, Patient, Research to Prevent Blindness, Visual impairment, Â, University, RPB, Ophthalmology, University of California, San Francisco, Pharmaceutical industry, Research, Medicine, Pancreatic serous cystadenoma

Research to Prevent Blindness (RPB) and Castle Biosciences today announced that they are partnering to increase opportunities for medical students to gain research experiences, specifically in the field of ocular cancer.

Key Points: 
  • Research to Prevent Blindness (RPB) and Castle Biosciences today announced that they are partnering to increase opportunities for medical students to gain research experiences, specifically in the field of ocular cancer.
  • For these reasons, it is important to incentivize new research in this area and to bring new talent into the ocular cancer field.
  • RPB and Castle Biosciences are providing funding for the RPB/Castle Biosciences Medical Student Eye Research Fellowship in Ocular Cancer, which allows medical students to take a year off from medical school to devote time to the pursuit of a research project within an RPB-supported department of ophthalmology (see list at end of document).
  • In 2022, the RPB/Castle Biosciences Medical Student Eye Research Fellowship in Ocular Cancer will award one fellowship to a medical student focusing on a research project related to ocular cancer.

Prevent Blindness Declares Third Annual Inherited Retinal Disease (IRD) Genetic Testing Week as May 16-22

Retrieved on: 
星期三, 五月 11, 2022
Advocacy, Genetic testing, Parent, Cone dystrophy, Visual impairment, University, YouTube, Leber congenital amaurosis, IRD, Instagram, Twitter, Strabismus, Research to Prevent Blindness, Genetic, Roche, Depression, Communication, Eye, Retina, Patient, University of Iowa Hospitals and Clinics, Caregiver, Program, Severe cognitive impairment, Pediatric ophthalmology, Diagnosis, Anxiety, Knowledge, Spark Therapeutics, Retinitis pigmentosa, Impact, Social isolation, LinkedIn, Disease, IRDS, US Commercial Real Estate Index, Lists of diseases, Visual Science, ID, CEO, Research, Social media, Therapy, Stargardt disease, Pharmaceutical industry, Empowerment, Ophthalmology, Facebook, Choroideremia

CHICAGO, May 11, 2022 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading nonprofit eye health and safety organization, has declared May 16-22, 2022 as the third annual "Inherited Retinal Disease (IRD) Genetic Testing Week." Educational materials, such as a fact sheet, social media graphics, and a dedicated webpage, preventblindness.org/inherited-retinal-diseases/, are available.

Key Points: 
  • CHICAGO, May 11, 2022 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's leading nonprofit eye health and safety organization, has declared May 16-22, 2022 as the third annual "Inherited Retinal Disease (IRD) Genetic Testing Week."
  • For the third consecutive year, IRD Genetic Testing Week at Prevent Blindness is supported by Spark Therapeutics , a fully integrated company and member of the Roche group dedicated to challenging the inevitability of genetic disease.
  • Inherited Retinal Diseases, also referred to as inherited retinal disorders, are a group of diseases that can cause severe vision loss or even blindness.
  • "Through early detection, specifically through genetic testing, and treatment, severe vision loss and blindness from Inherited Retinal Diseases can be avoided in many cases," said Jeff Todd, president and CEO of Prevent Blindness.

Tβ4 Shows Potential as a Combination Treatment for Diabetes-Induced Complications of the Cornea

Retrieved on: 
星期三, 五月 4, 2022
Thymosin beta-4, T4, U.S. Securities and Exchange Commission, Forward-looking statement, Research to Prevent Blindness, Private Securities Litigation Reform Act, University, Company, Hyperglycemia, Annual report, Physician, ARVO, Research, Security (finance), Association, Clinical trial, Risk, OTCQB, Patent, Association for Research in Vision and Ophthalmology, VIP, National, Form 10-K, Regeneration, Cornea, Method, University of Central Florida College of Optics and Photonics, Visual impairment, Diabetes, Wayne State University School of Medicine, Mansoura University, SEC, Vasoactive intestinal peptide, Pharmaceutical industry, EU, Vision, Ophthalmology

Furthermore, T4 strongly establishes its role as an adjunctive treatment for diabetic corneal impediments with no side effects, thereby easing the disadvantages of present methods of [eye] care," according to the research team.

Key Points: 
  • Furthermore, T4 strongly establishes its role as an adjunctive treatment for diabetic corneal impediments with no side effects, thereby easing the disadvantages of present methods of [eye] care," according to the research team.
  • The research was presented at the Association for Research in Vision and Ophthalmology (ARVO) 2022 meeting, held May 1-4, 2022, in Denver, Colorado.
  • RegeneRx is focused on the development of novel therapeutic peptides, including Thymosin beta 4 (T4) and its constituent fragments, for tissue and organ protection, repair, and regeneration.
  • The Company specifically disclaims any obligation to update this information, as a result of future events or otherwise, except as required by applicable law.

Prevent Blindness to Hold First-Ever A.S.P.E.C.T. Patient Advocacy and Engagement Summit in Washington, D.C.

Retrieved on: 
星期二, 五月 3, 2022
Advocacy, Youth Engagement Summit, Summit, Mallinckrodt, YouTube, Vision, Instagram, Twitter, Research to Prevent Blindness, Communication, Eye, Patient, Horizon Therapeutics, Program, Severe cognitive impairment, Human voice, Knowledge, Partner, Spark Therapeutics, Novartis, Willard, LinkedIn, Visual impairment, Public health, Life, CEO, BIO, Research, InterContinental, AR, Health insurance, Pharmaceutical industry, Medicine, Empowerment, Facebook

CHICAGO, May 3, 2022 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading non-profit eye health and safety organization, will be holding the inaugural A.S.P.E.C.T. Patient Advocacy and Engagement Summit, May 9-11, 2022, at the Willard InterContinental Hotel in Washington, D.C. The Summit will bring together trainees, allies, and program sponsors from across the country.

Key Points: 
  • Patient Advocacy and Engagement Summit, May 9-11, 2022, at the Willard InterContinental Hotel in Washington, D.C.
  • Patient Advocacy and Engagement Summit will include a variety of educational sessions and group exercises on topics such as:
    The A.S.P.E.C.T.
  • Patient Advocacy and Engagement Summit, contact Julie Grutzmacher at [email protected]
    Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight.
  • Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America.

Prevent Blindness and Regeneron Unite to Help Save Eyesight through the "Diabetes and the Eyes" Program

Retrieved on: 
星期三, 四月 27, 2022
Drug development, Center, CEO, Cancer, Korea Disease Control and Prevention Agency, Awareness, Pain, Medicine, Biotechnology, Eye disease, Monoclonal antibody, Severe cognitive impairment, Lists of diseases, Degenerative disease, Twitter, Eye, Research, Partner, Patient, Science, Identity management, Inflammation, YouTube, Education, Program, LinkedIn, Health minister, Infection, Mental health, Social media, Allergy, Laboratory, Diabetic retinopathy, Visual impairment, Clinical Science (journal), Communication, Research to Prevent Blindness, Instagram, Homegrown, Diabetes, Partnership, FDA, Disease, Quality of life, Risk, Allied health professions, Pharmaceutical industry, Facebook, Regeneron Pharmaceuticals

CHICAGO, April 27, 2022 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's oldest voluntary eye health and safety organization, and Regeneron Pharmaceuticals, Inc., are uniting to increase education on the impact diabetes can have on vision and eye health through an expanded "Diabetes and the Eyes" program. With the support of Regeneron, the program will now include a video series relevant for both English and Spanish speakers, community-level health education and support, and refreshed materials to increase awareness of diabetes' impact on vision.

Key Points: 
  • The impact that diabetes may have on vision, as well as quality of life, can be devastating," said Jeff Todd, president and CEO of Prevent Blindness.
  • "We thank Regeneron for their continued support and partnership to help save sight and maintain independence through the 'Diabetes and the Eyes' program."
  • Prevent Blindness created the "Diabetes and the Eyes" program in 2019 to provide much-needed educational resources to allied health personnel and consumers with the goal of helping to prevent vision loss due to diabetes.
  • Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America.

Prevent Blindness Declares March as Workplace Eye Wellness Month to Provide Sight-Saving Resources to Employees and their Employers

Retrieved on: 
星期一, 二月 28, 2022
Risk, Eye, Workplace, CDC, Sore, Twitter, Virus, Welding, Occupational safety and health, Center, Retina, Occupational Safety and Health Administration, IOL, Centers for Disease Control and Prevention, Bureau of Labor Statistics, American Optometric Association, Personal protective equipment, Conjunctiva, Eye injury, Safety, Tablet, Research to Prevent Blindness, Dust, System Infected: Backdoor VBS Dunihi, PPE, LinkedIn, Conjunctivitis, Bacteria, Infection, Screen time, OSHA, Laser, Visual impairment, GLARE, Instagram, Severe cognitive impairment, YouTube, Headache, CEO, Research, Time, Television, Camera, Facebook

CHICAGO, Feb. 28, 2022 /PRNewswire-PRWeb/ --March is Workplace Eye Wellness Month at Prevent Blindness , the nation's oldest eye health and safety nonprofit organization.

Key Points: 
  • CHICAGO, Feb. 28, 2022 /PRNewswire-PRWeb/ --March is Workplace Eye Wellness Month at Prevent Blindness , the nation's oldest eye health and safety nonprofit organization.
  • Prevent Blindness recommends that the type of eye protection that should be used depends on the hazards in the workplace.
  • Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight.
  • Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America.